September 2016

ProAxsis
Fri, 30/09/2016 - 10:12
ProAxsis Limited is pleased to announce that it has successfully registered a CE Mark for its novel ProteaseTag® Active Neutrophil Elastase Immunoassay.
Tue, 27/09/2016 - 09:00
Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, has completed a funding round worth £1.5M, including a direct investment of £650,000 from Mercia Technologies PLC.
Mon, 26/09/2016 - 15:30
Board member and Head of R&D at one of the world’s largest biotech companies to help select winner of new synthetic biology start-up competition
Wed, 21/09/2016 - 14:00
Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders
Wed, 21/09/2016 - 10:45
Leiden, The Netherlands, and Woburn, MA, 21st September 2016 / Sciad Newswire / Batavia Biosciences received an $8 million grant from the Bill &a
Mon, 19/09/2016 - 09:00
London, UK, 19th September 2016 / Sciad Newswire / SynbiCITE, in association with the Industrial Biotechnology Innovation Centre (IBiolC) will run another of its
Tue, 13/09/2016 - 18:00
SynBioBeta will be bringing together the synthetic biology community to recognize excellence in the industry for the 2nd Annual Engineering Biology Awards.
Tue, 13/09/2016 - 07:30
Keele, UK, 13th September 2016 / Sciad Newswire / Prokarium today announced the start of its programme to develop an oral vaccine against Zika virus infection.
Mon, 12/09/2016 - 12:45
London, UK, 12th September 2016 – The RSA Group, the world's largest Talent Consultancy in Life Sciences, has announced the appointment of a new CEO, Alex Bennett.
Mon, 12/09/2016 - 11:15
London, UK, 12th September 2016 / Sciad Newswire / NALIA Systems is pleased to announce the filing of two new patent applications that highlight the co

Pages